March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...
March 14, 2023 — The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the ...
March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 13, 2023 — BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...
March 13, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...
March 13, 2023 — iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions that ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 12, 2023 — As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed ...
March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with ...
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...
March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm, have ...
March 9, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...
March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...
March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...
March 14, 2023
